CD Markers
CD110


Topic Completed: 1 February 2002

Minor changes: 9 October 2020

Copyright: 2002-2021, PathologyOutlines.com, Inc.

PubMed Search: CD110 [title]

Nat Pernick, M.D.
Page views in 2020: 103
Page views in 2021 to date: 3
Cite this page: Pernick N. CD110. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/cdmarkerscd110.html. Accessed January 15th, 2021.
Definition / general
  • Also called thrombopoietin receptor (TPO-R), myeloproliferative leukemia virus oncogene (MPL)
  • Binding to thrombopoietin induces megakaryocyte proliferation and differentiation and prevents apoptosis
  • Mutations present in some patients with congenital amegakaryocytic thrombocytopenia, characterized by severe congenital thrombocytopenia with no megakaryocytes in the bone marrow (Hum Mutat 2006;27:296)
  • MPL mutations in myelofibrosis patients are associated with more severe anemia (Br J Haematol 2007;137:244)
  • Thrombopoietin receptor agonists may be useful for treating thrombocytopenia (Blood 2007;109:4739)
Uses by pathologists
  • Differentiate essential thrombocythemia (variable but weak/negative staining) from reactive thrombocytosis (positive staining, Blood 2002;99:4131)
Diagrams / tables

Images hosted on other servers:
Missing Image

Protein and site, various mutations

Positive staining - normal
  • Hematopoietic stem cells and progenitor cells (J Transl Med 2006;4:9), megakaryocytes and progenitors, platelets
Additional references
Back to top
Image 01 Image 02